COVID-19 vaccine maker shares sink as governments mull patent waiver

Shares of COVID-19 vaccine makers fell on Thursday as governments debated plans to waive patent protection for the shots, with analysts saying the move could rattle investor sentiment or weigh on longer-term business prospects. READ MORE